November 10, 2017 / 6:53 PM / 4 months ago

Pfizer exits China joint venture for generic drugs

(Reuters) - Pfizer Inc (PFE.N) said on Friday it has sold its 49 percent stake to exit a joint venture it had set up with China’s Zhejiang Hisun Pharmaceuticals (600267.SS) in 2012 to develop and market generic drugs.

FILE PHOTO: The Pfizer logo is seen at their world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly/File Photo

The U.S. drugmaker said it sold its stake in the venture, Hisun-Pfizer Pharmaceuticals Co Ltd, to Sapphire I Holdings Ltd. (

    The venture will change its name, but retain the rights to manufacture and sell all the drugs being marketed or developed in China, Pfizer and Hisun Pharma said in a joint statement.

    Pfizer’s shares were marginally lower in afternoon trading.

    Reporting by Divya Grover in Bengaluru; Editing by Savio D'Souza

    0 : 0
    • narrow-browser-and-phone
    • medium-browser-and-portrait-tablet
    • landscape-tablet
    • medium-wide-browser
    • wide-browser-and-larger
    • medium-browser-and-landscape-tablet
    • medium-wide-browser-and-larger
    • above-phone
    • portrait-tablet-and-above
    • above-portrait-tablet
    • landscape-tablet-and-above
    • landscape-tablet-and-medium-wide-browser
    • portrait-tablet-and-below
    • landscape-tablet-and-below